Zhigang Mei

2.4k total citations
91 papers, 1.7k citations indexed

About

Zhigang Mei is a scholar working on Molecular Biology, Neurology and Complementary and alternative medicine. According to data from OpenAlex, Zhigang Mei has authored 91 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 34 papers in Neurology and 20 papers in Complementary and alternative medicine. Recurrent topics in Zhigang Mei's work include Neurological Disease Mechanisms and Treatments (21 papers), Neuroinflammation and Neurodegeneration Mechanisms (12 papers) and Acupuncture Treatment Research Studies (10 papers). Zhigang Mei is often cited by papers focused on Neurological Disease Mechanisms and Treatments (21 papers), Neuroinflammation and Neurodegeneration Mechanisms (12 papers) and Acupuncture Treatment Research Studies (10 papers). Zhigang Mei collaborates with scholars based in China, United Kingdom and United States. Zhigang Mei's co-authors include Zhitao Feng, Jinwen Ge, Songbai Yang, Lipeng Du, Yue Zhou, Jun Liao, Hua-Jun Zhou, Xiaolu Liu, Yihui Deng and Danhong Liu and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and Free Radical Biology and Medicine.

In The Last Decade

Zhigang Mei

84 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhigang Mei China 24 696 432 268 253 240 91 1.7k
Xiang Fan China 27 855 1.2× 394 0.9× 227 0.8× 367 1.5× 117 0.5× 67 1.8k
Peng Ye China 29 1.0k 1.5× 251 0.6× 336 1.3× 155 0.6× 249 1.0× 127 2.6k
Yingze Ye China 19 819 1.2× 729 1.7× 220 0.8× 273 1.1× 128 0.5× 43 1.9k
Yi Zheng United States 31 769 1.1× 419 1.0× 147 0.5× 271 1.1× 77 0.3× 62 2.6k
Jiekun Luo China 22 770 1.1× 201 0.5× 163 0.6× 195 0.8× 220 0.9× 68 1.6k
Zhihong Jian China 27 1.0k 1.5× 853 2.0× 328 1.2× 371 1.5× 148 0.6× 73 2.7k
Jin‐Hua Gu China 22 840 1.2× 311 0.7× 220 0.8× 279 1.1× 90 0.4× 70 1.7k
Tao Jiang China 30 1.1k 1.6× 279 0.6× 641 2.4× 138 0.5× 202 0.8× 100 2.3k

Countries citing papers authored by Zhigang Mei

Since Specialization
Citations

This map shows the geographic impact of Zhigang Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhigang Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhigang Mei more than expected).

Fields of papers citing papers by Zhigang Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhigang Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhigang Mei. The network helps show where Zhigang Mei may publish in the future.

Co-authorship network of co-authors of Zhigang Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Zhigang Mei. A scholar is included among the top collaborators of Zhigang Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhigang Mei. Zhigang Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mei, Zhigang, et al.. (2025). Stroke with White Matter Lesions: Potential Pathophysiology and Therapeutic Targets. British Journal of Hospital Medicine. 86(3). 1–21. 1 indexed citations
2.
Ge, Jinwen, et al.. (2025). Naotaifang formula regulates Drp1-induced remodeling of mitochondrial dynamics following cerebral ischemia-reperfusion injury. Free Radical Biology and Medicine. 229. 139–153. 7 indexed citations
4.
Zhou, Junlin, Tong Yang, Yue Zhou, et al.. (2025). Insight into interplay between PANoptosis and autophagy: novel therapeutics in ischemic stroke. Frontiers in Molecular Neuroscience. 17. 1482015–1482015. 11 indexed citations
5.
Liu, Yang, et al.. (2025). Mitochondrial quality control in diabetes mellitus and complications: molecular mechanisms and therapeutic strategies. Cell Death and Disease. 16(1). 652–652. 2 indexed citations
7.
Liu, Yaxin, Jung Hwa Hong, Guozuo Wang, & Zhigang Mei. (2025). An emerging role of SNAREs in ischemic stroke: From pre-to post-diseases. Biochemical Pharmacology. 236. 116907–116907. 1 indexed citations
8.
Shi, Jiayi, Dandan Li, Yuhong Wang, et al.. (2024). THSG alleviates cerebral ischemia/reperfusion injury via the GluN2B–CaMKII–ERK1/2 pathway. Phytomedicine. 129. 155595–155595. 6 indexed citations
10.
Yang, Tong, et al.. (2024). Astragaloside IV combined with ligustrazine ameliorates abnormal mitochondrial dynamics via Drp1 SUMO/deSUMOylation in cerebral ischemia–reperfusion injury. CNS Neuroscience & Therapeutics. 30(4). e14725–e14725. 9 indexed citations
11.
Luo, Yanan, et al.. (2024). Electroacupuncture Ameliorates Cerebral Ischemia-Reperfusion Injury by Inhibiting Pyroptosis through the Sirtuin-1 Pathway. World Journal of Traditional Chinese Medicine. 11(1). 101–111. 1 indexed citations
12.
Liu, Tongtong, Rui Fang, Feng Qiu, et al.. (2024). A novel rat model of cerebral small vessel disease based on vascular risk factors of hypertension, aging, and cerebral hypoperfusion. Hypertension Research. 47(8). 2195–2210. 3 indexed citations
13.
Guo, Xiang, Jinkai Zhang, Zhitao Feng, et al.. (2024). The antiangiogenic effect of total saponins of Panax japonicus C.A. Meyer in rheumatoid arthritis is mediated by targeting the HIF-1α/VEGF/ANG-1 axis. Journal of Ethnopharmacology. 333. 118422–118422. 13 indexed citations
14.
Ma, Xiaoqi, et al.. (2023). Novel insight into cGAS-STING pathway in ischemic stroke: from pre- to post-disease. Frontiers in Immunology. 14. 1275408–1275408. 22 indexed citations
15.
Yang, Tong, Zhigang Mei, Xiaolu Liu, et al.. (2021). An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury. Drug Design Development and Therapy. Volume 15. 3783–3808. 20 indexed citations
17.
Wu, Bingxin, et al.. (2020). Efficacy and safety of the classic Chinese herbal prescription Sanpian decoction on migraine: A meta-analysis. EXPLORE. 16(5). 318–327. 8 indexed citations
18.
Wei, Tao, Songbai Yang, Jinfeng Wang, et al.. (2018). The Antiapoptosis Effect of Geum japonicum Thunb. var. chinense Extracts on Cerebral Ischemia Reperfusion Injury via PI3K/Akt Pathway. Evidence-based Complementary and Alternative Medicine. 2018(1). 7290170–7290170. 16 indexed citations
19.
Mei, Zhigang, et al.. (2014). Treatment of tinnitus with electrical stimulation on acupoint in the distribution area of ear vagus nerve combining with sound masking: randomized controlled trial. World Journal of Acupuncture - Moxibustion. 24(2). 30–35. 11 indexed citations
20.
Mei, Zhigang. (2011). Cholinergic Anti-inflammatory Pathway and its Application in Traditional Chinese Medicine Research. Lishizhen Medicine and Materia Medica Research. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026